Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
2018 · New England Journal of Medicine · 651 citations
https://doi.org/10.1056/nejmoa1803164
B
Barbara Walley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
3.7K
Citations
21
h-index
27
i10-index
Barbara Walley is an academic researcher from University of Calgary. The author has contributed to research in topics: Estrogen and related hormone effects & Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies. The author has an h-index of 21, co-authored 40 publications.
ORCID: 0000-0002-9618-905XPapers by this author
worksAbsolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials
2016 · Journal of Clinical Oncology · 178 citations
https://doi.org/10.1200/jco.2015.64.3171
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
2019 · Journal of Clinical Oncology · 145 citations
https://doi.org/10.1200/jco.18.01967
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials
2017 · Journal of Clinical Oncology · 142 citations
https://doi.org/10.1200/jco.2016.72.0946
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials
2013 · The Breast · 86 citations
https://doi.org/10.1016/j.breast.2013.08.009
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
2016 · Breast Cancer Research · 28 citations
https://doi.org/10.1186/s13058-016-0771-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat